Sökning: "Bengt Isaksson"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden Bengt Isaksson.
1. Insulin resistance in pancreatic cancer
Sammanfattning : The dismal prognosis of pancreatic cancer (PC) is related to metabolic complications of the tumor. Impaired glucose tolerance or diabetes due to insulin resistance, and cachexia are observed early and frequently in these patients. The basic mechanisms of PC-associated insulin resistance and weight loss are not fully understood. LÄS MER
2. Clinical studies of RNA as a prognostic and diagnostic marker for disease
Sammanfattning : Technologies for RNA detection are evolving rapidly and gives an op-portunity for discovery of new markers for early detection of complex diseases. Today in clinical work we rely on signs and symptoms in com-bination with the measurement of protein levels for diagnosis. LÄS MER
3. Future Train Traffic Control : Development and deployment of new principles and systems in train traffic control
Sammanfattning : The train traffic control system of the future requires new solutions and strategies in order to better meet tomorrow’s demands and goals. Uppsala University and Trafikverket have been collaborating for several years in research regarding train traffic control and how to improve traffic controllers’ support systems and working environment. LÄS MER
4. Symptoms, prehospital delay and long-term survival in men vs. women with myocardial infarction : a combined register and qualitative study
Sammanfattning : The general aim of this thesis was to study symptoms, prehospital delay and time trends in long-term survival in men and women with myocardial infarction (MI). The study was based on quantitative and qualitative data collections. LÄS MER
5. Colorectal Liver Metastases : Onco-surgical Strategies & Prognostic Factors
Sammanfattning : The management of patients with colorectal cancer with liver metastases has improved over the past decades. There have been significant developments in terms of surgery, local therapies, anesthesia and oncological treatment. Nevertheless, there is no consensus on what constitutes optimal treatment strategy. LÄS MER